97
Views
21
CrossRef citations to date
0
Altmetric
Drug Evaluation

Rivastigmine in vascular dementia

, , , &
Pages 1399-1410 | Published online: 25 Feb 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Claudie Charbonneau, Fadi Massoud, Marc Dorais & Jacques LeLorier. (2008) A retrospective study of cholinesterase inhibitors for Alzheimer's disease: cerebrovascular disease as a predictor of patient outcomes. Current Medical Research and Opinion 24:12, pages 3287-3294.
Read now
Francesco Amenta, Daniele Tomassoni, Enea Traini, Fiorenzo Mignini & Franco Veglio. (2008) Nicardipine: A Hypotensive Dihydropyridine-Type Calcium Antagonist with a Peculiar Cerebrovascular Profile. Clinical and Experimental Hypertension 30:8, pages 808-826.
Read now
Maria Luisa Onor, Marianna Trevisiol & Eugenio Aguglia. (2007) Rivastigmine in the treatment of Alzheimer’s disease: an update. Clinical Interventions in Aging 2:1, pages 17-32.
Read now
Hubert H Fernandez, Gregory P Crucian, Michael S Okun, Catherine C Price & Dawn Bowers. (2005) Mild cognitive impairment in Parkinson’s disease: the challenge and the promise. Neuropsychiatric Disease and Treatment 1:1, pages 37-50.
Read now
Abhilash K Desai & George T Grossberg. (2005) Rivastigmine for Alzheimer’s disease. Expert Review of Neurotherapeutics 5:5, pages 563-580.
Read now
Gustavo C Román. (2005) Rivastigmine for subcortical vascular dementia. Expert Review of Neurotherapeutics 5:3, pages 309-313.
Read now
Roger Bullock. (2005) Treatment of behavioural and psychiatric symptoms in dementia: implications of recent safety warnings. Current Medical Research and Opinion 21:1, pages 1-10.
Read now

Articles from other publishers (14)

A. S. Avedisova, A. B. Guekht, K. V. Zakharova & R. G. Akzhigitov. (2018) The efficacy of pharmacological approaches to therapy of the apathy syndrome in dementia disorders (the review). Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 118:4, pages 126.
Crossref
Yan Xiao, Zhi-Zhong Guan, Chang-Xue Wu, Yi Li, Shi-Xiang Kuang & Jin-Jing Pei. (2011) Correlations Between Cholinesterase Activity and Cognitive Scores in Post-Ischemic Rats and Patients with Vascular Dementia. Cellular and Molecular Neurobiology 32:3, pages 399-407.
Crossref
Rita MorettiPaola Torre, Rodolfo M. Antonello, Giuseppe Cazzato & Gilberto Pizzolato. (2008) Different Responses to Rivastigmine in Subcortical Vascular Dementia and Multi-Infarct Dementia. American Journal of Alzheimer's Disease & Other Dementiasr 23:2, pages 167-176.
Crossref
G. Marc, F. Etcharry-Bouyx & F. Dubas. (2007) Demenze vascolari. EMC - Neurologia 7:1, pages 1-11.
Crossref
Sönke Arlt & Holger Jahn. (2006) Pharmacological treatment of non-Alzheimer dementias. Current Opinion in Psychiatry 19:6, pages 642-648.
Crossref
Martin R. Farlow. (2006) Use of Antidementia Agents in Vascular Dementia: Beyond Alzheimer Disease. Mayo Clinic Proceedings 81:10, pages 1350-1358.
Crossref
Rita Moretti, Paola Torre, Rodolfo M. Antonello & Giuseppe Cazzato. (2006) Behavioral Alterations and Vascular Dementia. The Neurologist 12:1, pages 43-47.
Crossref
G. Marc, F. Etcharry-Bouyx & F. Dubas. (2006) Démences vasculaires. EMC - Neurologie 3:4, pages 1-11.
Crossref
Alistair Burns, John O'Brien & David AmesGustavo Román. 2005. Dementia 3Ed. Dementia 3Ed 574 600 .
Roger M. Lane & Martin R. Farlow. (2005) Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease. Journal of Lipid Research 46:5, pages 949-968.
Crossref
Gustavo C. Román. (2005) Cholinergic dysfunction in vascular dementia. Current Psychiatry Reports 7:1, pages 18-26.
Crossref
Keith Edwards, Barbara Koumaras, Michael Chen, Ibrahim Gunay & Dario Mirski. (2005) Long-Term Effects of Rivastigmine Treatment on the Need for Psychotropic Medications in Nursing??Home Patients with Alzheimer???s Disease. Clinical Drug Investigation 25:8, pages 507-515.
Crossref
. (2005) Current awareness in human psychopharmacology. Human Psychopharmacology: Clinical and Experimental 20:1, pages 75-86.
Crossref
. (2004) Current awareness in geriatric psychiatry. International Journal of Geriatric Psychiatry 19:12, pages 1211-1218.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.